NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The problem is you keep saying these things and then going off in strange and incorrect tangents that are factually false. They revised their trial, prior to unblinding to address these issues and they endpoints they chose, and got approved, along with the use of the External Control Arm, a new FDA policy NWBO had pointed out long before and then submitted a comment letter about the revised policy.

Things you hypothesize happened have not happened repeatedly, like causing confoundment because you claimed they had engaged in double dosage.

Or that they filed their revised SAP after data lock you claim, also not true, because you read the revised language in their filings later.

And apparently you were not around when much of this was happening and being discussed.